- Statement from FDA Commissioner Scott Gottlieb🔍
- FDA Announces Next Steps in Cannabis Regulation🔍
- FDA Concludes that Existing Regulatory Frameworks for Foods and ...🔍
- FDA announces new steps related to cannabis products🔍
- FDA Announces Its Next Steps for Cannabis Products – Cannabis ...🔍
- FDA Announces New Steps and Actions Regarding Cannabis and ...🔍
- Federal Policy Developments Relating to Cannabis🔍
- US DEA will reclassify marijuana🔍
FDA Announces Next Steps in Cannabis Regulation
Statement from FDA Commissioner Scott Gottlieb, M.D., on new ...
FDA is announcing a number of important new steps and actions to ... Among other things, this law established a new category of cannabis ...
FDA Announces Next Steps in Cannabis Regulation
The U.S. Food and Drug Administration (FDA) has announced that it will take a number of steps to advance its consideration for the potential ...
FDA Concludes that Existing Regulatory Frameworks for Foods and ...
Today we are announcing that after careful review, the FDA has concluded that a new regulatory pathway for CBD is needed that balances ...
FDA announces new steps related to cannabis products - Feedstuffs
The Food & Drug Administration has announced new steps to advance the agency's continued evaluation of potential regulatory pathways for cannabis-containing ...
FDA Announces Its Next Steps for Cannabis Products – Cannabis ...
On April 2, 2019, departing FDA Commissioner Scott Gottlieb issued a statement about FDA's next steps to advance a regulatory pathway for cannabis-containing ...
FDA Announces New Steps and Actions Regarding Cannabis and ...
The U.S. Food and Drug Administration (FDA) has recently taken significant steps toward establishing a regulatory framework for cannabis and ...
Federal Policy Developments Relating to Cannabis - LeadingAge
In May 2024 the US Department of Justice Drug Enforcement Agency (DEA) initiated a formal rulemaking process to consider moving marijuana from a schedule I to ...
US DEA will reclassify marijuana, ease restrictions, AP sources say
The U.S. Drug Enforcement Administration will move to reclassify marijuana as a less dangerous drug, a historic shift to generations of American ...
FDA Announces a Path Forward for CBD Consumer Products
Cannabis industry stakeholders waiting for the US Food and Drug Administration (FDA) to forge a regulatory path forward for cannabidiol ...
FDA Regulation of Cannabis and Cannabis-Derived Products
Drugs must generally either receive premarket approval by FDA through the New Drug Application (NDA) process or conform to a "monograph" for a particular drug ...
Justice Department Submits Proposed Regulation to Reschedule ...
The Justice Department today announced that the Attorney General has submitted to the Federal Register a notice of proposed rulemaking ...
FDA Issues Statement on Cannabis Regulation and Announces ...
On April 2, 2019, the Federal Food and Drug Administration (FDA) outlined new steps to advance review of potential regulatory pathways for ...
DOJ Proposes Rescheduling Marijuana, But the Outlook for ...
FDA Regulation and Potential Enforcement. Rescheduling would not alter marijuana's status as a new drug requiring FDA approval under the Federal ...
Health Care Alert: FDA Announces Public Hearing to Inform ... - Vorys
The public hearing and related comment period announced by the FDA are intended to inform the agency's decision-making process regarding whether ...
FDA Cannabis Regulation: Help Us Make Your Voice Heard
Tucker Ellis can help companies find their way as the new regulatory environment unfolds, as well as make your questions and concerns known. FDA has announced ...
Proposed Cannabis Reschedule Sidesteps State Law Effects
The FDA finally threw in the towel in early 2023, announcing that “a new regulatory pathway for CBD is needed” and urging Congress to pass ...
FDA Talks Cannabis Next Steps, Announces Public Hearing
In doing so, the FDA can continue to enforce the law to protect the public from unsafe products, while also providing a potential regulatory ...
FDA asks Congress to legislate CBD approval pathway, as new law ...
The law also requires HHS to ensure an “adequate and uninterrupted supply” of marijuana to scientists approved under the new streamlined process. These actions ...
Federal Regulation of Hemp: Next Steps From The FDA
The FDA has outlined the next steps in their evaluation of potential regulatory pathways for cannabis derived products, including hemp-derived CBD products.
Breaking: DEA Turns a New Leaf in Drug Policy, Moves Toward ...
In October of 2022, President Biden requested federal agencies to review marijuana classification and in August of 2023, HHS gave their recommendation to move ...